[Disseminated histoplasmosis in AIDS]

Area of Science:

• Infectious Diseases
• Mycology
• Immunocompromised Hosts

Background:

• Human Immunodeficiency Virus type 1 (HIV-1) infection compromises the immune system, increasing susceptibility to opportunistic infections.
• Disseminated histoplasmosis, caused by Histoplasma capsulatum, is a serious systemic fungal infection, particularly in individuals with advanced HIV-1.

Observation:

• A 41-year-old male HIV-1 patient presented with high fever, nonproductive cough, and dyspnea, initially suspected as Pneumocystis pneumonia.
• Elevated lactate dehydrogenase levels and bone marrow examination revealing macrophages with Histoplasma capsulatum inclusions confirmed disseminated histoplasmosis.
• Initial treatment with co-trimoxazole was ineffective, highlighting the need for specific antifungal therapy.

Findings:

• Diagnosis of disseminated histoplasmosis was confirmed via bone marrow biopsy, fungal culture, and serological testing for Histoplasma antigen.
• Treatment with amphotericin B resulted in rapid symptom regression.
• Subsequent maintenance therapy with itraconazole achieved sustained remission and prevented recurrence.

Implications:

• This case underscores the importance of considering disseminated fungal infections, such as histoplasmosis, in immunocompromised patients presenting with non-specific respiratory symptoms.
• Early and accurate diagnosis, followed by appropriate antifungal treatment (amphotericin B and itraconazole), is crucial for managing disseminated histoplasmosis in HIV-1 patients.
• Effective treatment strategies can lead to favorable outcomes and long-term disease control in this vulnerable population.